These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18629778)

  • 81. Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer.
    Mori R; Wang Q; Danenberg KD; Pinski JK; Danenberg PV
    Prostate; 2008 Oct; 68(14):1555-60. PubMed ID: 18651557
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Profile of anterior gradient 3 (AGR3) mRNA expression and serum levels in benign and malignant breast tumors.
    Prihantono P; Rahardjo W; Syamsu SA; Smaradhania N
    Breast Dis; 2021; 40(S1):S39-S43. PubMed ID: 34057117
    [TBL] [Abstract][Full Text] [Related]  

  • 83. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.
    Brooks JD; Cairns P; Shore RE; Klein CB; Wirgin I; Afanasyeva Y; Zeleniuch-Jacquotte A
    Cancer Epidemiol; 2010 Dec; 34(6):717-23. PubMed ID: 20627767
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dynamic Changes of Circulating Mir-155 Expression and the Potential Application as a Non-Invasive Biomarker in Breast Cancer.
    Anwar SL; Tanjung DS; Fitria MS; Kartika AI; Sari DNI; Rakhmina D; Wardana T; Astuti I; Haryana SM; Aryandono T
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):491-497. PubMed ID: 32102529
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of secreted glyceraldehyde-3-phosphate dehydrogenase in the infection mechanism of enterohemorrhagic and enteropathogenic Escherichia coli: interaction of the extracellular enzyme with human plasminogen and fibrinogen.
    Egea L; Aguilera L; Giménez R; Sorolla MA; Aguilar J; Badía J; Baldoma L
    Int J Biochem Cell Biol; 2007; 39(6):1190-203. PubMed ID: 17449317
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
    Swellam M; Ramadan A; El-Hussieny EA; Bakr NM; Hassan NM; Sobeih ME; EzzElArab LR
    J Cell Biochem; 2019 Aug; 120(8):12321-12330. PubMed ID: 30825229
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison between LightCycler Real-Time Polymerase Chain Reaction (PCR) assay with serum and PCR-enzyme-linked immunosorbent assay with whole blood samples for the diagnosis of human brucellosis.
    Queipo-Ortuño MI; Colmenero JD; Baeza G; Morata P
    Clin Infect Dis; 2005 Jan; 40(2):260-4. PubMed ID: 15655745
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Canine glyceraldehyde-3-phosphate dehydrogenase complementary DNA: polymerase chain reaction amplification, cloning, partial sequence analysis, and use as loading control in ribonuclease protection assays.
    Gröne A; Weckmann MT; Capen CC; Rosol TJ
    Am J Vet Res; 1996 Mar; 57(3):254-7. PubMed ID: 8669750
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Quantitation of estrogen receptor mRNA copy numbers in breast cancer cell lines and tumors.
    Poola I; Williams DM; Koduri S; Ramprakash J; Taylor RE; Hankins WD
    Anal Biochem; 1998 May; 258(2):209-15. PubMed ID: 9570831
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Correlation between serum level of chemokine (C-C motif) ligand 18 and poor prognosis in breast cancer.
    Sun JH; Fan N; Zhang Y
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706714
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?
    Attallah AM; El-Far M; Omran MM; Abdallah SO; El-Desouky MA; El-Dosoky I; Abdelrazek MA; Attallah AA; Elweresh MA; Abdel Hameed GE; Shawki HA; Salama KS; El-Waseef AM
    Tumour Biol; 2014 Nov; 35(11):10737-45. PubMed ID: 25073515
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients.
    Li D; Li P; Wu J; Yi J; Dou Y; Guo X; Yin Y; Wang D; Ma C; Qiu L
    Clin Chim Acta; 2018 Sep; 484():81-86. PubMed ID: 29775621
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein-protein interactions.
    Seifert KN; McArthur WP; Bleiweis AS; Brady LJ
    Can J Microbiol; 2003 May; 49(5):350-6. PubMed ID: 12897829
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer.
    Nour Eldin EEM; Nour Eldein MM; El-Readi MZ; Mirza AA; Fatani SH; Al-Amodi HS; Althubiti MA; Al-Ezzi EM; Eid SY; Kamel HFM
    Oncol Res Treat; 2020; 43(10):506-517. PubMed ID: 32721979
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size.
    Singer CF; Mogg M; Koestler W; Pacher M; Marton E; Kubista E; Schreiber M
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4003-9. PubMed ID: 15217931
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Expression of glyceraldehyde-3-phosphate dehydrogenase on the surface of Clostridium perfringens cells.
    Matsunaga N; Shimizu H; Fujimoto K; Watanabe K; Yamasaki T; Hatano N; Tamai E; Katayama S; Hitsumoto Y
    Anaerobe; 2018 Jun; 51():124-130. PubMed ID: 29753109
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.
    Panagiotou G; Papakonstantinou E; Vagionas A; Polyzos SA; Mantzoros CS
    J Clin Endocrinol Metab; 2019 Feb; 104(2):349-358. PubMed ID: 30388235
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Advances in the DNA Nanotechnology for the Cancer Biomarkers Analysis: Attributes and Applications.
    Xia LY; Tang YN; Zhang J; Dong TY; Zhou RX
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1105-1119. PubMed ID: 34979273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.